RVI vs Buying AI Stocks Directly: Which Strategy Returns More Over 5 Years?

Over 5 years, buying AI stocks directly wins on cost — RVI's 2.5% fee compounds into a ~13% drag — but RVI wins on access, because ~70% of its NAV is private OpenAI, SpaceX, and Anthropic stakes you can't buy any other way. That's the short answer. The longer answer is more interesting.

Robinhood Ventures Fund I (NYSE: RVI) and a do-it-yourself basket of public AI stocks look like they're solving the same problem — "give me exposure to the AI boom." They aren't. One sells you something you literally cannot buy on an exchange and charges you for the privilege; the other is free and liquid but stops at the IPO line. Picking between them is a question about what you're actually paying for.

RVI vs Buying AI Stocks Directly: The Side-by-Side Comparison

RVI versus buying AI stocks directly comes down to a single trade: access to private companies in exchange for a 2.5% annual fee and a closed-end fund's NAV premium. A self-built basket of public AI names costs roughly 0%, trades instantly, and lets you control every position — but it cannot hold pre-IPO OpenAI, SpaceX, or Anthropic, which together are about a third of RVI's portfolio. The table below lays out where each strategy wins.

Figures based on Robinhood's most recent RVI shareholder disclosures and typical zero-commission brokerage pricing as of mid-2026. Not investment advice.

The 5-Year Return Math: RVI vs AI Stocks Directly

Start with $10,000 in each. Assume both portfolios' underlying holdings appreciate at the same hypothetical 15% per year — generous, but it keeps the comparison clean. The only structural difference is RVI's 2.5% fee. After five years the direct basket compounds to about $20,100, while RVI nets roughly $17,800 after fees — a gap of about $2,300, or 13% of the starting stake, created entirely by the fee.

But that math assumes identical underlying returns, and that's the catch. RVI's private names don't move like public stocks. If OpenAI re-prices from $500B to $1T in a single funding round, RVI captures a markup no public AI basket can — because you simply cannot own pre-IPO OpenAI on the open market. The fee is the price of that optionality. The question is whether the private upside beats the 13% drag.

What You Get With RVI That AI Stocks Directly Can't Give You

There is exactly one reason to pay RVI's 2.5% fee instead of buying AI stocks directly: the private holdings. As of mid-2026, RVI's top positions are companies with no ticker you can type into a brokerage app:

That's the entire value proposition in one table. You can replicate RVI's theme with public stocks — Nvidia, Microsoft, Alphabet, Meta, Broadcom — but you cannot replicate its holdings. If the next leg of AI value accrues to still-private foundation-model companies before they list, the direct route misses it. Compare these private marks to public comps on our AI Valuations dashboard.

What Buying AI Stocks Directly Gives You That RVI Can't

The direct route's advantages are unglamorous but real, and they compound. First, cost: a basket of public AI stocks at a zero-commission broker runs ~0% versus RVI's 2.5%, and even a broad AI ETF tops out around 0.75%. Second, no NAV premium — you always pay exactly what the asset is worth, where RVI's closed-end structure has at times added a 10%+ premium on top of the fee.

Third, control. You decide whether Nvidia is 30% of your portfolio or 5%. You can sell a loser to harvest a tax loss in December and rebuy a related name. You can rebalance the day the thesis changes. RVI hands you a fixed portfolio where the top 10 names are ~70% of NAV and you own all of it or none of it. For investors who want to express a view rather than buy a pre-packaged one, the direct route is structurally better — and it's the cheaper of the two by a wide margin.

Which Strategy Returns More Over 5 Years? The Verdict

On pure expected cost, buying AI stocks directly wins — full stop. The ~13% five-year fee drag plus the risk of paying a NAV premium is a hole RVI has to climb out of every single year. For most investors who simply want AI exposure and already can't stomach the private-market illiquidity, the honest answer is to build the basket yourself and skip the fee.

RVI wins in exactly one scenario: you specifically want pre-IPO OpenAI, SpaceX, and Anthropic, you believe those private marks will compound faster than public AI names, and you accept paying 2.5% a year for access you can't get otherwise. That's a real thesis — frontier AI value has been accruing to private companies — but it's a narrower bet than "I want AI exposure." Size it accordingly, and verify what you're buying on the Robinhood RVI Fund dashboard.